Skip to main content
Figure 8 | Virology Journal

Figure 8

From: Characterization of a branched lipopeptide candidate vaccine against influenza A/Puerto Rico 8/34 which is recognized by human B and T-cell immune responses

Figure 8

Ability of 16 different T-B and B-T influenza peptides, HIV gag peptide (HIV) and recombinant A/New Caledonia/20/99 hemagglutinin protein (rHA NC) to bind neutralizing antibodies in sheep serum positive against A/New Caledonia/20/99 strain, and thereby inhibit neutralization of A/New Caledonia/20/99 influenza virus. Number of viral plaques given as mean of duplicates at a 1/80 dilution of plasma ± SEM. Background (number of plaques in peptide-free serum wells) was subtracted from each plaque count.

Back to article page